Home  /  Resource Library  /  Efficacy of venetoclax in high risk relapsed mantle cell lymphoma (MCL) – outcomes and mutation profile from venetoclax resistant MCL patients

Efficacy of venetoclax in high risk relapsed mantle cell lymphoma (MCL) – outcomes and mutation profile from venetoclax resistant MCL patients

Results of a study investigating venetoclax as salvage therapy in the treatment of mantle cell lymphoma.